Development of a Novel GABAB Receptor Modulator as an Alternative to Phenibut: Insights from Molecular Modeling and In Vivo Studies
C1 is a promising alternative to phenibut, demonstrating enhanced anxiolytic effects and a favourable safety profile. Further studies are warranted to confirm its clinical potential.
Authors
- A. V. Kolobov
- Sergey Shityakov (ORCID: https://orcid.org/0000-0002-6953-9771)
- Viacheslav Kravtsov (ORCID: https://orcid.org/0000-0003-3910-5160)
- K. L. Ovchinnikov (ORCID: https://orcid.org/0000-0002-9924-3859)
- Samson Olusegun Afolabi (ORCID: https://orcid.org/0000-0002-6174-5044)
- Maria Netesa
- Ekaterina V. Skorb
Institutions
- ITMO University (RU)
- Yaroslavl State Technical University (RU)
- Institute of Experimental Medicine (RU)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.2174/011570159x407182251104183509
- Primary Topic
- Alcoholism and Thiamine Deficiency
- Type
- article
- Field-Weighted Citation Impact
- 0.00